Abstract

The invention aims to the development of new synthetic analogs of 3-iodothyronamine (T1AM), an exponent of a class of endogenous molecules derived from thyroid hormones. The possible main therapeutic uses are: treatment of obesity and dyslipidemia,neuro-psychiatric and behavioral disorders,neurodegenerative diseases.

Research Institution

Università di Pisa

Numero di pubblicazione

WO2015151068A1

TRL

n.a.

Technologies, Systems, Applications

Biomedical, New drugs development